Cargando…
BRAF-targeted therapy alters the functions of intratumoral CD4(+) T cells to inhibit melanoma progression
The establishment of an immunosuppressive tumor microenvironment is a hallmark feature driving cancer cell evasion of immunosurveillance. In a murine melanoma model, we recently demonstrated that decreased intratumoral CD4(+) T-cell expression of CD40L and interferon γ (IFNγ) is critical to maintain...
Autores principales: | Ho, Ping-Chih, Kaech, Susan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106160/ https://www.ncbi.nlm.nih.gov/pubmed/25083331 http://dx.doi.org/10.4161/onci.29126 |
Ejemplares similares
-
Altering the intratumoral localization of macrophages to inhibit cancer progression
por: Casazza, Andrea, et al.
Publicado: (2014) -
BRAF-targeted therapy and immune responses to melanoma
por: Ngiow, Shin Foong, et al.
Publicado: (2013) -
Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma
por: Smalley, Keiran SM, et al.
Publicado: (2015) -
Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma
por: Cooper, Zachary A, et al.
Publicado: (2014) -
Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma
por: Cooper, Zachary A., et al.
Publicado: (2013)